Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 8/2011

01.12.2011 | Original Article

Impact of CT-based diagnostic imaging on management and outcome of nonfunctioning pancreatic tumors

verfasst von: Katja Maschuw, Volker Fendrich, Peter Langer, C. Volland, Annette Ramaswamy, Detlef K. Bartsch

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Sporadic malignant non-functioning pancreatic endocrine tumors (NF-PETs) are an important subset of pancreatic neoplasms. The aim of this study was to assess the impact of improved imaging on these features in a tertiary referral centre within a 20-year follow-up.

Patients and methods

From 1988 to 2009, 51 patients were treated for sporadic malignant NF-PETs. Forty-one patients who underwent tumor resection were retrospectively attributed according to the date of the initial diagnosis, group 1: 1988–1999 vs. group 2: 2000–2009.

Results

Cross-sectional imaging led to positive prediction of NF-PETs in all patients. Curative resection was achieved in 76%. Synchronous metastases were present in 56% with a positive prediction of 43%. In group 1, the mean reported CT-determined tumor size was 56 vs. 54 mm in group 2 (p = 0.89). Synchronous metastases were present in 61% in group 1 vs. 57% (p = 0.99) in group 2. Metachronous metastases were recorded in 39% in group 1 vs. 43% (p = 0.84) in group 2. The mean interval from initial resection to diagnosis of metastatic disease was significantly shorter (p = 0.01) in patients from group 1 (14 vs. 61 months). Cumulative 5- and 10-year survival rates were 77% and 72% in group 1 vs. a 5-year survival rate of 66% in group 2.

Conclusion

So far, improved CT-based imaging has no impact on earlier detection of initial synchronous metastases in sporadic malignant NF-PETs, while metachronous metastases are detected earlier.
Literatur
1.
Zurück zum Zitat Öberg K, Eriksson B (2005) Endocrine tumors of the pancreas. Best Pract Res Clin Gastroenterol 19:753–781PubMedCrossRef Öberg K, Eriksson B (2005) Endocrine tumors of the pancreas. Best Pract Res Clin Gastroenterol 19:753–781PubMedCrossRef
2.
Zurück zum Zitat Akerstrom G, Hessman O, Hellman P et al (2005) Pancreatic tumors as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol 19:819–830PubMedCrossRef Akerstrom G, Hessman O, Hellman P et al (2005) Pancreatic tumors as part of the MEN-1 syndrome. Best Pract Res Clin Gastroenterol 19:819–830PubMedCrossRef
3.
Zurück zum Zitat Solcia E, Kloeppel G, Sobin LH (2000) World Health Organization: international histological classification of tumours: histological typing of endocrine rumours. Springer, Berlin Solcia E, Kloeppel G, Sobin LH (2000) World Health Organization: international histological classification of tumours: histological typing of endocrine rumours. Springer, Berlin
4.
Zurück zum Zitat Touzios JG, Kiely JM, Pitt SC et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241:776–785PubMedCrossRef Touzios JG, Kiely JM, Pitt SC et al (2005) Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg 241:776–785PubMedCrossRef
5.
Zurück zum Zitat Cadiot G, Vuagnat A, Doukhan I et al (1999) Prognostic factors in patients with Zollinger- Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116:286–293PubMedCrossRef Cadiot G, Vuagnat A, Doukhan I et al (1999) Prognostic factors in patients with Zollinger- Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology 116:286–293PubMedCrossRef
6.
Zurück zum Zitat Yu F, Venzon DJ, Serrano J et al (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 17:615–630PubMed Yu F, Venzon DJ, Serrano J et al (1999) Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 17:615–630PubMed
7.
Zurück zum Zitat Sarmiento JM, Que FG, Grant CS et al (2002) Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 132:976–983PubMedCrossRef Sarmiento JM, Que FG, Grant CS et al (2002) Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach. Surgery 132:976–983PubMedCrossRef
8.
Zurück zum Zitat Fendrich V, Waldmann J, Bartsch DK, Langer P (2009) Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 6:419–428PubMedCrossRef Fendrich V, Waldmann J, Bartsch DK, Langer P (2009) Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 6:419–428PubMedCrossRef
9.
Zurück zum Zitat Panzuto F, Nasoni S, Falconi M et al (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr-Relat Cancer 12:1083–1092PubMedCrossRef Panzuto F, Nasoni S, Falconi M et al (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr-Relat Cancer 12:1083–1092PubMedCrossRef
10.
Zurück zum Zitat Bettini R, Boninsegna L, Mantovani W et al (2008) Prognostic factors at diagnosis and value of WHO classification in a mono- institutional series of 180 non-functioning pancreatic endocrine tumors. Ann Oncol 19:903–908PubMedCrossRef Bettini R, Boninsegna L, Mantovani W et al (2008) Prognostic factors at diagnosis and value of WHO classification in a mono- institutional series of 180 non-functioning pancreatic endocrine tumors. Ann Oncol 19:903–908PubMedCrossRef
11.
Zurück zum Zitat Sofuni A, Iijima H, Moriyasu F et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroeneterology 40(5):518–525CrossRef Sofuni A, Iijima H, Moriyasu F et al (2005) Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroeneterology 40(5):518–525CrossRef
12.
Zurück zum Zitat Papanikalaou IS, Adler A, Neumann U, Neuhaus P, Rösch T (2009) Endoscopic ultrasound in pancreatic disease—its influence on surgical decision-making. An update 2008. Pancreatology 9(1–2):55–65CrossRef Papanikalaou IS, Adler A, Neumann U, Neuhaus P, Rösch T (2009) Endoscopic ultrasound in pancreatic disease—its influence on surgical decision-making. An update 2008. Pancreatology 9(1–2):55–65CrossRef
13.
Zurück zum Zitat Seemann MD, Meisterschlaeger G, Gaa J, Rummeny EJ (2008) Assessment of the extent of metastasis of gastrointestinal carcinoid tumors using whole body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 11(2):58–65 Seemann MD, Meisterschlaeger G, Gaa J, Rummeny EJ (2008) Assessment of the extent of metastasis of gastrointestinal carcinoid tumors using whole body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 11(2):58–65
14.
Zurück zum Zitat Krausz Y, Keidar Z, Kogan I et al (2003) SPECT/CT hybride imaging with 111- in- pentetreotide in assessment of neuroendocrine tumors. Clin Endocrinol 59:565–573CrossRef Krausz Y, Keidar Z, Kogan I et al (2003) SPECT/CT hybride imaging with 111- in- pentetreotide in assessment of neuroendocrine tumors. Clin Endocrinol 59:565–573CrossRef
15.
Zurück zum Zitat Bartsch DK, Schilling T, Ramaswamy A (2000) Management of nonfunctioning islet cell carcinomas. World J Surg 24(11):1418–1424PubMedCrossRef Bartsch DK, Schilling T, Ramaswamy A (2000) Management of nonfunctioning islet cell carcinomas. World J Surg 24(11):1418–1424PubMedCrossRef
16.
Zurück zum Zitat Rindi G, Klöppel G, Alhman H et al (2006) TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401PubMedCrossRef Rindi G, Klöppel G, Alhman H et al (2006) TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401PubMedCrossRef
17.
Zurück zum Zitat Liu Y, Song Q, Jin HT et al (2009) The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas. La Radiologica Medica 114(8):1232–1238CrossRef Liu Y, Song Q, Jin HT et al (2009) The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas. La Radiologica Medica 114(8):1232–1238CrossRef
18.
Zurück zum Zitat Norton JA, Kivlen M, Li M et al (2003) Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 138:859–866PubMedCrossRef Norton JA, Kivlen M, Li M et al (2003) Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg 138:859–866PubMedCrossRef
19.
Zurück zum Zitat Mörk H, Ignee A, Schuessler G (2007) Analysis of neuroendocrine tumor metastasis in the liver using contrast enhanced ultrasonogaphy. Scand J Gastroenterol 42(5):652–662PubMedCrossRef Mörk H, Ignee A, Schuessler G (2007) Analysis of neuroendocrine tumor metastasis in the liver using contrast enhanced ultrasonogaphy. Scand J Gastroenterol 42(5):652–662PubMedCrossRef
20.
Zurück zum Zitat Fendrich V, Langer P, Celik I et al (2006) An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 244(6):845–851PubMedCrossRef Fendrich V, Langer P, Celik I et al (2006) An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg 244(6):845–851PubMedCrossRef
21.
Zurück zum Zitat Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumors (CT/MR/US). Best Pract Res Clin Endocrinol Metab 21(1):43–68PubMedCrossRef Rockall AG, Reznek RH (2007) Imaging of neuroendocrine tumors (CT/MR/US). Best Pract Res Clin Endocrinol Metab 21(1):43–68PubMedCrossRef
22.
Zurück zum Zitat Capurso G, Falconi M, Panzuto F et al (2009) Risk factors for sporadic pancreatic endocrine tumors: a case–control study for prospectively evaluated patients. Am J Gastroenterol 1004(12):3034–3041CrossRef Capurso G, Falconi M, Panzuto F et al (2009) Risk factors for sporadic pancreatic endocrine tumors: a case–control study for prospectively evaluated patients. Am J Gastroenterol 1004(12):3034–3041CrossRef
Metadaten
Titel
Impact of CT-based diagnostic imaging on management and outcome of nonfunctioning pancreatic tumors
verfasst von
Katja Maschuw
Volker Fendrich
Peter Langer
C. Volland
Annette Ramaswamy
Detlef K. Bartsch
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 8/2011
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-011-0748-0

Weitere Artikel der Ausgabe 8/2011

Langenbeck's Archives of Surgery 8/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.